Plasmapheresis in myasthenia gravis. A survey

Transfusion Science

Volumn 19, Issue 2, 1998, Pages 129-136

  Kuks, J B M ^a   Skallebaek, D ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN;

ARTICLE; DISEASE COURSE; DRUG MEGADOSE; HEADACHE; HUMAN; HYPOCALCEMIA; HYPOTENSION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MYASTHENIA GRAVIS; NAUSEA; PATHOGENESIS; PLASMAPHERESIS; PRURITUS; THORAX PAIN; URTICARIA;

ADJUVANTS, IMMUNOLOGIC; CLINICAL TRIALS; HUMANS; MYASTHENIA GRAVIS; PLASMAPHERESIS;

EID: 0031725877     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(98)00022-8     Document Type: Article

References (45)

1. Lefvert AK, Matell G: Thoracic duct lymph drainage in my asthenia gravis: clinical effect and kinetic studies of the acetylcholine receptor antibodies, in Dau PC (ed): Plasmapheresis and the Immunobiology of Myasthenia Gravis. Boston, Houghton Mifflin, 1979; pp. 151-160.
2. Dunn JM: Neonatal myasthenia. Am J Obst Gyn 1976; 125:265-266.
3. Pinching AJ, Peters DK, Newsom Davis J: Remission of myasthenia gravis following plasma-exchange. Lancet 1976; 2:1373-1376.
4. Dau PC, Lindstrom JM, Cassel CK, et al.: Plasmapheresis and immunosuppressive therapy in myasthenia gravis. N Engl J Med 1977; 297:1134-1140.
5. Kornfeld P, Ambinder EP, Mittag T, Bender AN, Papatestas AE, Goldberg J, Genkins G: Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 1981; 38:478-481.
6. Nielsen VK, Paulson OB, Rosenkvist J, Holsoe E, Lefvert AK: Rapid improvement of myasthenia gravis after plasma exchange. Ann Neurol 1982; 11:160-169.
7. Durelli L, Cocito D, Bergamini L: Rapid improvement of myasthenia gravis after plasma exchange? Ann Neurol 1983; 13:220-221.
8. Lisak RP, Abramsky O, Schotland DL: Plasmapheresis in the treatment of myasthenia gravis: preliminary studies in 21 patients, in Dau PC (ed): Plasmapheresis and the immunobiology of myasthenia gravis. Boston, Houghton Mifflin, 1979; pp. 209-215.
9. Olarte MR, Schoenfeldt RS, Penn AS, Lovelace RE, Rowland LP: Effect of plasmapheresis in myasthenia gravis 1978-1980. Ann NY Acad Sci 1981; 377:725-728.
10. Thorlacius S, Aarli JA, Jacobsen H, Halvorsen K: Plasma exchange in myasthenia gravis, clinical effect. Acta Neurol Scand 1985; 72:464-468.
11. Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG: Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978; 28:266-272.
12. Reuther P, Wiebecke D, Hertel G, Ricker K: Plasma exchange and immunosuppressive drugs in myasthenia gravis. Ann NY Acad Sci 1981; 377:869-870.
13. Hawkey CJ, Newsom-Davis J, Vincent A: Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy. J Neurol Neurosurg Psychiat 1981; 44:469-475.
14. Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C: Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 1981; 377:729-743.
15. Fornadi L, Horvath R, Szobor A: Myasthenia Gravis: Treatment with plasma exchange. Experience over 10 years. Acta Med Hung 1991; 48:137-144.
16. Perlo VP, Shahani BT, Huggins CE, Hunt J, Kosinski K, Potts F: Effect of plasmapheresis in myasthenia gravis. Ann NY Acad Sci 1981; 377:709-727.
17. Olanow CW, Wechsler AS, Roses AD: A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis. Ann Surg 1982; 196:113-121.
18. Fornasari PM, Riva G, Piccolo G, et al. Short and long term clinical effects of plasma exchange in 33 cases of myasthenia gravis. Int J Artific Organs 1985; 8:159-162.
19. Gajdos Ph., Chevret S, Clair B, Tranchant C, Chastang C: Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997; 41:789-796.
20. Dau PC: Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 1981; 377:700-708.
21. Antozzi C, Gemma M, Regi B, et al. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 1991; 238:103-107.
22. Tindall RSA, Rollins J: Apheresis in the treatment of myasthenia gravis, in M. Valbonesi, AA Pineda, JC Biggs (eds): Therapeutic Hemapheresis, Milan, Publ.: Wichtig Editore, 1986; pp. 43-52.
23. D'Empaire G, Hoaglin DC, Perlo VP, Pontoppidan H: Effect of prethymectomy plasma exchange on postoperative respiratory function in myasthenia gravis. J Thorac Cardiovasc Surg 1985; 89:592-596.
24. Thorlacius S, Mollnes TE, Garred P, Aarli JA, Matre R, Tönder O, Halvorsen K: Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulins. Acta Neurol Scand 1988; 78:221-227.
25. Sanders DB, Howard JF, Johns TR, Campa JF: High-dose daily prednison in the treatment of myasthenia gravis, in Dau PC (eds): Plasmapheresis and the immunobiology of myasthenia gravis. Boston, Houghton Mifflin, 1979 pp. 289-306.
26. Levine SE, Keesey JC: Successful plasmapheresis for fulminant myasthenia gravis during pregnancy. Arch Neurol 1986; 43:197-198.
27. Miller RG, Milner-Brown HS, Dau PC: Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange. Muscle & Nerve 1981; 5:255.
28. Oosterhuis H. J. G. H., Limburg PC, Hummel-Tappel E: The TH: Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. J Neurol Sci 1983; 58:371-385.
29. Mossman S, Vincent A, Newsom-Davis J: Myasthenia Gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986; i:116-118.
30. Lang AE, Humphrey JG, Gordon DA: Plasma exchange therapy for severe penicillamine-induced myasthenia gravis. J Rheumatol 1981; 8:303-307.
31. Gajdos Ph, Outin HD, Elkharrat D, et al. High dose intervenous gamma globulin for myasthenia gravis. Lancet 1984; i: 406-407.
32. Steg RE, Lefkowitz DM: Immunoadsorption plasmapheresis for severe generalised myasthenia gravis. ArchDis-Child 1993; 69:236-238.
33. Carter B, Harrison R, Lunt GG, Behan PO, Simpson JA: Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. J Neurol Neurosurg Psychiat 1980; 43:397-402.
34. Seybold ME, Tsoukas C, Lindstrom J, Fong S, Vaughan J: Leukoplasmapheresis for myasthenia gravis.Acetylcholine receptor antibody production. Arch Neurol 1982; 39:433-435.
35. Fujishita S, Motomura M, Ohishi K, Kanazawa H, Shibuya N: Plasmapheresis changes lymphocyte subsets in myasthenia gravis. Apheresis 1990; pp. 297-299.
36. Riley TL, Monaghan WP: Antireceptor antibody decline without improvement after plasmapheresis in myasthenia gravis. Ann Intern Med 1980; 92:713.
37. Roses AD, Olanow CW, McAdams MW, Lane RJM: No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology (NY) 1981; 31:220-224.
38. Newsom-Davis J, Wilson SG, Vincent A, Ward CD: Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979; 1:464-468.
39. Rodnitzky RL, Bosch EP: Chronic long-interval plasma exchange in myasthenia gravis. Arch Neurol 1984; 41:715-717.
40. Consensus Conference: The utility of therapeutic plasmapheresis for Neurological disorders. JAMA 1986; 256:1333-1337.
41. Grob D, Simpson D, Mitsumoto H, et al.: Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995; 45:338-344.
42. Shibuya N, Sato T, Osame M, Takegami T, Doi S, Kawanami S: Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry 1994; 57:578-581.
43. Edan G, Landgraf F: Experience with intravenous immunoglobulin in myasthenia gravis: a review. J Neurol Neurosurg Psychiatry 1994; 57:55-56.
44. Dalakas MC: High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 1994; 44:223-226.
45. Stricker RB, Kwiatkowska BJ, Habis JA, Kiprov DD: Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin. Arch Neurol 1993; 50:837-840.